Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: Results of a phase I trial

Journal of Allergy and Clinical Immunology

Volumn 111, Issue 4, 2003, Pages 854-861

  Fellrath, Jean Marc ^a   Kettner, Alexander ^a,b   Dufour, Nathalie ^a   Frigerio, Christian ^a   Schneeberger, Dominique ^a   Leimgruber, Annette ^a   Corradin, Gampietro ^b   Spertini, François ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Allergy; Anergy; Bee venom; IL 10; Immunotherapy; Long synthetic peptides; Phospholipase A2; TH1 TH2; Tolerance

Indexed keywords

ALBUMIN; BEE VENOM; EPITOPE; GAMMA INTERFERON; INTERLEUKIN 10; LONG SYNTHETIC PEPTIDE; LONG SYNTHETIC PEPTIDE[1-60]; LONG SYNTHETIC PEPTIDE[47-99]; LONG SYNTHETIC PEPTIDE[90-134]; PEPTIDE; PHOSPHOLIPASE A2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOKINE PRODUCTION; FEMALE; HUMAN; HYPERSENSITIVITY; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; LYMPHOCYTE PROLIFERATION; MALE; PEPTIDE MAPPING; PRIORITY JOURNAL; SAFETY; T LYMPHOCYTE; TH1 CELL;

EID: 0037395291     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2003.1337     Document Type: Article

References (38)

1. Müller U, Helbling A, Berchtold E. Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety. J Allergy Clin Immunol 1992;89:529-35.
2. Rueff F, Przybilla B. Ultrarush immunotherapy in patients with Hymenoptera venom allergy. J Allergy Clin Immunol 2001;107:928-9.
3. Kämmerer R, Kettner A, Chvatchko Y, Dufour N, Tiercy JM, Corradin G, et al. Delineation of PLA(2) epitopes using short or long overlapping synthetic peptides: interest for specific immunotherapy. Clin Exp Allergy 1997;27:1016-26.
4. Kämmerer R, Chvatchko Y, Kettner A, Dufour N, Corradin G, Spertini F. Modulation of T-cell response to phospholipase A2 and phospholipase A2- derived peptides by conventional bee venom immunotherapy. J Allergy Clin Immunol 1997;100:96-103.
5. Müller U, Akdis CA, Fricker M, Akdis M, Blesken T, Bettens F, et al. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. J Allergy Clin Immunol 1998;101:747-54.
6. Norman PS, Ohman JL Jr, Long AA, Creticos PS, Gefter MA, Shaked Z, et al. Treatment of cat allergy with T-cell reactive peptides. Am J Respir Crit Care Med 1996;154:1623-8.
7. King TP, Lu G, Agosto H. Antibody responses to bee melittin (Api m 4) and hornet antigen 5 (Dol m 5) in mice treated with the dominant T-cell epitope peptides. J Allergy Clin Immunol 1998;101:397-403.
8. Bauer L, Bohle B, JahnSchmid B, Wiedermann U, Daser A, Renz H, et al. Modulation of the allergic immune response in BALB/c mice by subcutaneous injection of high doses of the dominant T cell epitope from the major birch pollen allergen Bet v 1. Clin Exp Immunol 1997;107:536-41.
9. Briner TJ, Kuo MC, Keating KM, Rogers BL, Greenstein JL. Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d 1. Proc Natl Acad Sci U S A 1993;90:7608-12.
10. van Neerven JR, vant'Hof W, Ringrose JH, Jansen HM, Aalberse RC, Wierenga EA, et al. T cell epitopes of house dust mite major allergen Der p II. J Immunol 1993;151:2326-35.
11. van Neerven RJ, van de Pol MM, van Milligen FJ, Jansen HM, Aalberse RC, Kapsenberg ML. Characterization of cat dander-specific T lymphocytes from atopic patients. J Immunol 1994;152:4203-10.
12. Oldfield WL, Kay AB, Larche M. Allergen-derived T cell peptide-induced late asthmatic reactions precede the induction of antigen-specific hyporesponsiveness in atopic allergic asthmatic subjects. J Immunol 2001;167:1734-9.
13. von Garnier C, Astori M, Kettner A, Dufour N, Heusser C, Corradin G, et al. Allergen-derived long peptide immunotherapy down-regulates specific IgE response and protects from anaphylaxis. Eur J Immunol 2000;30:1638-45.
14. Müller HL. Diagnosis and treatment of insect sensitivity. J Asthma Res 1966;3:331-3.
15. Müller U, Mosbech H. Position paper: Immunotherapy with hymenoptera venoms. Allergy 1993;48(Suppl 14):37-46.
16. Müller UR, Dudler T, Schneider T, Crameri R, Fischer H, Skrbic D, et al. Type I skin reactivity to native and recombinant phospholipase A(2) from honeybee venom is similar. J Allergy Clin Immunol 1995;96:395-402.
17. Roggero MA, Servis C, Corradin G. A simple and rapid procedure for the purification of synthetic polypeptides by a combination of affinity chromatography and methionine chemistry. FEBS Lett 1997;408:285-8.
18. Jutel M, Wyss-Coray T, Carballido JM, Blaser K, Muller UR, Pichler WJ. Selective restimulation of antigen or allergen preactivated T cells using OKT3 F(ab)(2) results in the secretion of TH-1 or TH-2-like cytokine patterns. Clin Exp Allergy 1995;25:1108-17.
19. Kettner A, Henry H, Hughes GJ, Corradin G, Spertini F. IgE and T-cell responses to high-molecular weight allergens from bee venom. Clin Exp Allergy 1999;29:394-401.
20. Akdis CA, Blesken T, Akdis M, Wuthrich B, Blaser K. Role of interleukin 10 in specific immunotherapy. J Clin Invest 1998;102:98-106.
21. Haselden BM, Kay AB, Larche M. Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions. J Exp Med 1999;189:1885-94.
22. Müller UR. Insect sting allergy: clinical picture, diagnosis and treatment. Stuttgart/New York: Gustav Fischer Verlag; 1990.
23. Tsitoura DC, DeKruyff RH, Lamb JR, Umetsu DT. Intranasal exposure to protein antigen induces immunological tolerance mediated by functionally disabled CD4+ T cells. J Immunol 1999;163:2592-600.
24. Hoyne GF, Askonas BA, Hetzel C, Thomas WR, Lamb JR. Regulation of house dust mite responses by intranasally administered peptide: transient activation of CD4+ T cells precedes the development of tolerance in vivo. Int Immunol 1996;8:335-42.
25. Pape KA, Merica R, Mondino A, Khoruts A, Jenkins MK. Direct evidence that functionally impaired CD4+ T cells persist in vivo following induction of peripheral tolerance. J Immunol 1998;160:4719-29.
26. Malvey EN, Jenkins MK, Mueller DL. Peripheral immune tolerance blocks clonal expansion but fails to prevent the differentiation of TH1 cells. J Immunol 1998;161:2168-77.
27. Astori M, von Garnier C, Kettner A, Dufour N, Corradin G, Spertini F. Inducing tolerance by intranasal administration of long peptides in naive and primed CBA/J mice. J Immunol 2000;165:3497-505.
28. Groux H, Bigler M, de Vries JE, Roncarolo MG. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J Exp Med 1996;184:19-29.
29. Akdis CA, Blaser K. IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: two key steps in specific immunotherapy. FASEB J 1999;13:603-9.
30. de Waal Malefyt R, Yssel H, de Vries JE. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells: specific inhibition of IL-2 production and proliferation. J Immunol 1993;150:4754-65.
31. H2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest 1999;103:175-83.
32. Müller U, Helbling A, Bischof M. Predictive value of venom-specific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honey bee venom. Allergy 1989;44:412-8.
33. Urbanek R, Kemeny DM, Richards D. Sub-class of IgG anti-bee venom antibody produced during bee venom immunotherapy and its relationship to long-term protection from bee stings and following termination of venom immunotherapy. Clin Allergy 1986;16:317-22.
34. Lesourd B, Paupe J, Thiollet M, Moulias R, Sainte-Laudy J, Scheinmann P. Hymenoptera venom immunotherapy, I: induction of T cell-mediated immunity by honeybee venom immunotherapy: relationships with specific antibody responses. J Allergy Clin Immunol 1989;83:563-71.
35. Ollert MW, Rakoski J, Jessberger B. Prognostic value of immunoblotting in patients on immunotherapy with hymenoptera venom. J Allergy Clin Immunol 2000;105:S59. [Abstract 178].
36. Schneider T, Lang AB, Carballido JM, Santamaria Babi LF, Dudler T, Kagi MK, et al. Human monoclonal or polyclonal antibodies recognize predominantly discontinuous epitopes on bee venom phospholipase A2. J Allergy Clin Immunol 1994;94:61-70.
37. Akdis CA, Akdis M, Blesken T, Wymann D, Alkan SS, Muller U, et al. Epitope-specific T cell tolerance to phospholipase A(2) in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. J Clin Invest 1996;98:1676-83.
38. Jutel M, Pichler WJ, Skrbic D, Urwyler A, Dahinden C, Müller UR. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures. J Immunol 1995;154:4187-94.